Update on supply of Zovirax Ophthalmic Ointment (aciclovir 3%)

Zovirax Ophthalmic Ointment (aciclovir 3%) is impacted by an ongoing global supply constraint with no confirmed resupply date in Australia.

We sincerely regret the inconvenience this is causing patients, pharmacists and doctors.

For up-to-date and ongoing supply updates of Zovirax Ophthalmic Ointment, please visit the Therapeutic Goods Administration (TGA) website.

The supply shortage is caused by an issue affecting aciclovir, the product’s active pharmaceutical ingredient (API), which did not meet specifications and resulted in a retail level recall in October 2014.  We continue to work diligently with our API supplier to resolve this issue as quickly as possible.

If you have any questions or concerns about Zovirax Ophthalmic Ointment, talk to your ophthalmologist or other health professional.

Doctors and pharmacists who require additional information should contact GSK medical information enquiries on 1800 033 109.

Related news

 

 - ends - 

 

For media enquiries please contact:

Kim O'Donohue
Communications Manager Pharmaceuticals
0477 322 431
kim.j.odonohue@gsk.com